These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
515 related items for PubMed ID: 12516586
1. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages. Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586 [No Abstract] [Full Text] [Related]
2. Prescription drug advertising--should states regulate what is false and misleading? Shaeffer J. Food Drug Law J; 2003 Feb; 58(4):629-48. PubMed ID: 15027454 [No Abstract] [Full Text] [Related]
3. When ads trump evidence: is direct-to-consumer advertising leading practice? Nelson R. Am J Nurs; 2007 Oct; 107(10):25-6. PubMed ID: 17895720 [No Abstract] [Full Text] [Related]
5. Dealing with drug advertising. The FDA can't always enforce the rules on misleading ads. Atkinson HG. Health News; 2003 Feb; 9(2):5. PubMed ID: 12632541 [No Abstract] [Full Text] [Related]
6. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption. Poser S. Food Drug Law J; 2007 Feb; 62(4):653-94. PubMed ID: 18557225 [No Abstract] [Full Text] [Related]
7. Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role? Waxman HA. Health Aff (Millwood); 2004 Feb; Suppl Web Exclusives():W4-256-8. PubMed ID: 15452002 [Abstract] [Full Text] [Related]
9. Direct-to-consumer advertising--where does the public interest lie? Saunders B. N Z Med J; 2003 Aug 22; 116(1180):U557; discussion U557. PubMed ID: 14581978 [No Abstract] [Full Text] [Related]
10. US aims to tighten rules on direct-to-consumer drug ads. Vastag B. Nat Biotechnol; 2007 Mar 22; 25(3):267. PubMed ID: 17344868 [No Abstract] [Full Text] [Related]
11. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine. Allen MC. Spec Law Dig Health Care Law; 1998 Dec 22; (236):9-29. PubMed ID: 10187553 [No Abstract] [Full Text] [Related]
12. The new drug marketing: a consumer protection perspective. Woodward D. Food Drug Law J; 1996 Dec 22; 51(4):637-50. PubMed ID: 11797733 [No Abstract] [Full Text] [Related]
13. New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit? Toop L, Richards D, Saunders B. N Z Med J; 2003 Aug 22; 116(1180):U556; discussion U556. PubMed ID: 14581976 [No Abstract] [Full Text] [Related]